Renal Ewing Sarcoma Mimicking Neuroblastoma: A Multitracer PET/Scintigraphic Imaging Pitfall.

Clin Nucl MedJul 27, 2026 (epub)

Nivedita Kundu, Dikhra Khan, Sambit Sagar et al.

✦ AI-curated · Sources linked

Case in brief

A 6-year-old boy presented with a left suprarenal mass initially suspected to be neuroblastoma. An inconclusive biopsy led to further imaging, where I-131 mIBG scintigraphy showed no uptake, Ga-68 DOTANOC PET/CT indicated mild somatostatin receptor expression, and F-18 FDG PET/CT revealed intense hypermetabolism. A repeat biopsy confirmed renal Ewing sarcoma through EWSR1 gene rearrangement.

What made this case unusual

The case illustrates the diagnostic challenge posed by renal Ewing sarcoma, which can mimic neuroblastoma on imaging, particularly with discordant molecular imaging findings.

Diagnostic / clinical pearl

Clinicians should consider renal Ewing sarcoma in pediatric patients with mIBG-negative, FDG-avid lesions, especially when somatostatin receptor expression is low.

Why it matters

This case underscores the importance of multimodality nuclear imaging in accurately diagnosing pediatric renal masses, potentially preventing misdiagnosis and inappropriate management.

Source

Published in Clin Nucl Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Nuclear Medicine

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.